Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 20 de 23
Filter
1.
Infect Control Hosp Epidemiol ; : 1-10, 2022 Feb 28.
Article in English | MEDLINE | ID: covidwho-2322300

ABSTRACT

Non-specific respiratory symptoms overlap with coronavirus disease 2019 (COVID-19). Prompt diagnosis of COVID-19 in hospital employees is crucial to prevent nosocomial transmission. Rapid molecular SARS-CoV-2 testing was performed for 115 symptomatic employees. The case positivity rate was 2.6%. Employees with negative tests returned to work after 80 +/- 28 minutes.

2.
Cureus ; 15(3): e36258, 2023 Mar.
Article in English | MEDLINE | ID: covidwho-2298306

ABSTRACT

Acute coronavirus 2 (SARS-CoV-2) infection usually results in mild symptoms, but secondary infections after SARS-CoV-2 infection can occur, particularly with comorbid conditions. We present the clinical course of a healthy adolescent with a brain abscess and life-threatening intracranial hypertension requiring emergent decompressive craniectomy after a SARS-CoV-2 infection. A 13-year-old healthy immunized male presented with invasive frontal, ethmoid, and maxillary sinusitis and symptoms of lethargy, nausea, headache, and photophobia due to a frontal brain abscess diagnosed three weeks after symptoms and 11 days of oral amoxicillin treatment. Coronavirus disease 2019 (COVID-19) reverse transcription-polymerase chain reaction (RT-PCR) was negative twice but then positive on amoxicillin day 11 (symptom day 21), when magnetic resonance imaging revealed a 2.5-cm right frontal brain abscess with a 10-mm midline shift. The patient underwent emergent craniotomy for right frontal epidural abscess washout and functional endoscopic sinus surgery with ethmoidectomy. On a postoperative day one, his neurological condition showed new right-sided pupillary dilation and decreased responsiveness. His vital signs showed bradycardia and systolic hypertension. He underwent an emergent decompressive craniectomy for signs of brain herniation. Bacterial PCR was positive for Streptococcus intermedius, for which he received intravenous vancomycin and metronidazole. He was discharged home on hospital day 14 without neurological sequelae and future bone flap replacement. Our case highlights the importance of timely recognition and treatment of brain abscess and brain herniation in patients with neurological symptoms after SARS-CoV-2 infection, even in otherwise healthy patients.

3.
Perspect Biol Med ; 65(4): 521-528, 2022.
Article in English | MEDLINE | ID: covidwho-2154206

ABSTRACT

The foundation story of bioethics is, as Susan Reverby (2009) argues, one of a trinity of horror stories culminating in what we commonly call the "Tuskegee Syphilis Study." The foundation story emphasizes that medical researchers violated participant autonomy by deceiving them about their medical conditions, the goals of the study, and the treatments they would receive, and by failing to consider the health and best interests of the research participant. While this story reflects some key elements of the Tuskegee study, it is only a selection of all the possible facts that, as a consequence, deflects attention from equally salient and problematic elements of the Public Health Service's unethical study and its context. Those elements not included in the bioethics foundation story represent the types of racial and social inequities that COVID-19 and other contemporary events have thrown into stark relief. If bioethics plans to emphasize translational work around public policy and public engagement understood broadly, then it will need to revise and expand the story it tells about itself and its founding.


Subject(s)
Bioethics , COVID-19 , United States , Humans , Health Personnel , Public Health
4.
Clin Infect Dis ; 2021 Nov 15.
Article in English | MEDLINE | ID: covidwho-1886371

ABSTRACT

BACKGROUND: Since its emergence in late 2019, SARS-CoV-2 continues to pose a risk to healthcare personnel (HCP) and patients in healthcare settings. Although all clinical interactions likely carry some risk of transmission, human actions like coughing and care activities like aerosol-generating procedures likely have a higher risk of transmission. The rapid emergence and global spread of SARS-CoV-2 continues to create significant challenges in healthcare facilities, particularly with shortages of personal protective equipment (PPE) used by HCP. Evidence-based recommendations for what PPE to use in conventional, contingency, and crisis standards of care continue to be needed. Where evidence is lacking, the development of specific research questions can help direct funders and investigators. OBJECTIVE: Develop evidence-based rapid guidelines intended to support HCP in their decisions about infection prevention when caring for patients with suspected or known COVID-19. METHODS: IDSA formed a multidisciplinary guideline panel including frontline clinicians, infectious disease specialists, experts in infection control, and guideline methodologists with representation from the disciplines of public health, medical microbiology, pediatrics, critical care medicine and gastroenterology. The process followed a rapid recommendation checklist. The panel prioritized questions and outcomes. Then a systematic review of the peer-reviewed and grey literature was conducted. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach was used to assess the certainty of evidence and make recommendations. RESULTS: The IDSA guideline panel agreed on eight recommendations, including two updated recommendations and one new recommendation added since the first version of the guideline. Narrative summaries of other interventions undergoing evaluations are also included. CONCLUSIONS: Using a combination of direct and indirect evidence, the panel was able to provide recommendations for eight specific questions on the use of PPE for HCP providing care for patients with suspected or known COVID-19. Where evidence was lacking, attempts were made to provide potential avenues for investigation. There remain significant gaps in the understanding of the transmission dynamics of SARS-CoV-2 and PPE recommendations may need to be modified in response to new evidence. These recommendations should serve as a minimum for PPE use in healthcare facilities and do not preclude decisions based on local risk assessments or requirements of local health jurisdictions or other regulatory bodies.

5.
Clin Infect Dis ; 74(6): 1089-1092, 2022 03 23.
Article in English | MEDLINE | ID: covidwho-1703666

ABSTRACT

Across 20 vaccine breakthrough cases detected at our institution, all 20 (100%) infections were due to variants of concern (VOCs) and had a median Ct of 20.2 (IQR, 17.1-23.3). When compared with 5174 contemporaneous samples sequenced in our laboratory, VOCs were significantly enriched among breakthrough infections (P < .05).


Subject(s)
COVID-19 , SARS-CoV-2 , Base Sequence , COVID-19/epidemiology , COVID-19/prevention & control , COVID-19 Vaccines , Humans , Washington/epidemiology
7.
Emerg Infect Dis ; 27(9): 2340-2348, 2021 Sep.
Article in English | MEDLINE | ID: covidwho-1435934

ABSTRACT

We investigated the risk of coronavirus disease (COVID-19)- patients transmitting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to emergency medical service (EMS) providers, stratified by aerosol-generating procedures (AGP), in King County, Washington, USA, during February 16-July 31, 2020. We conducted a retrospective cohort investigation using a statewide COVID-19 registry and identified 1,115 encounters, 182 with ≥1 AGP. Overall, COVID-19 incidence among EMS personnel was 0.57 infections/10,000 person-days. Incidence per 10,000 person-days did not differ whether or not infection was attributed to a COVID-19 patient encounter (0.28 vs. 0.59; p>0.05). The 1 case attributed to a COVID-19 patient encounter occurred within an at-risk period and involved an AGP. We observed a very low risk for COVID-19 infection attributable to patient encounters among EMS first responders, supporting clinical strategies that maintain established practices for treating patients in emergency conditions.


Subject(s)
COVID-19 , Emergency Medical Services , Aerosols , Humans , Infectious Disease Transmission, Patient-to-Professional , Retrospective Studies , SARS-CoV-2
8.
Epidemiology ; 33(2): 193-199, 2022 03 01.
Article in English | MEDLINE | ID: covidwho-1393350

ABSTRACT

BACKGROUND: The National Football League (NFL) and National Football League Players Association implemented a set of strict protocols for the 2020 season with the intent to mitigate COVID-19 risk among players and staff. In that timeframe, the league's 32 teams completed 256 regular season games and several thousand meetings and practices. In parallel, community cases of COVID-19 were highly prevalent. We assess the risk of holding a 2020 NFL season by comparing community and player COVID-19 infections. METHODS: We used county-level COVID-19 test data from each team to establish baseline distributions of infection rates expected to occur in a population similar in age and sex to NFL players. We used a binomial distribution to simulate expected infections in each community cohort and compared these findings with observed COVID-19 infections in players. RESULTS: Over a 5-month period (1 August 2020 to 2 January 2021), positive NFL player infections (n = 256) were 55.7% lower than expected when compared with simulations from NFL community cohorts. For 30 of 32 teams (94%), observed counts fell at or below expectation, including 28 teams (88%) for which rates were lower. Two teams fell above baseline expectation. CONCLUSIONS: The NFL/NFLPA protocols that governed team facilities, travel, gameday, and activities outside of the workplace were associated with lower infection rates among NFL players compared with the surrounding community. The NFL's 2020-2021 season are consistent with the hypothesis that robust testing and behavioral protocols support a safe return to sport and work.


Subject(s)
COVID-19 , Football , Cohort Studies , Humans , SARS-CoV-2 , Seasons
10.
The Journal of Hospital Ethics ; 7(2):94-96, 2021.
Article in English | ProQuest Central | ID: covidwho-1239427

ABSTRACT

Lynch et al present a case wherein an extracorporeal mechanical oxygenation needed to be turned off. Erica Samson was an otherwise healthy 20-year-old colleae student when she contracted the coronavirus. Her intensive care unit (ICU) team was puzzled until Erica's mother told them that as a child she had had asthma on and off. Now that they had an answer for why her lungs were not improving, they flew Erica to the regional, tertiary care center with the expectation of putting her on ECMO. ECMO stands for extracorporeal mechanical oxygenation and is the most sophisticated machinery that could help Erica. As time goes on, and the ethical dimensions of ECMO technology when applied to COVID-19 continue to be assessed, what we can hopefully expect are appropriate regulations being developed and implemented, so as to better condition the outcomes of patients like Erica.

11.
The Journal of Hospital Ethics ; 7(2):90-93, 2021.
Article in English | ProQuest Central | ID: covidwho-1239397

ABSTRACT

Cederquist et al discuss a case involving shared decision making in the presence of COVID-19 and the absence of families. A 47 years old woman was brought by ambulance to her community hospital emergency room, where she was diagnosed with hypoxic respiratory failure secondary to COVID-19. The family was updated regularly by the Intensive Care Unit (ICU) team. The family requested, then insisted, on continued, full life-sustaining treatmen. Over a period of a week or more, multiple goals of care conversations were conducted, including vide-oconferences to demonstrate the patient's devastating neurologic injury. Like so many in the acute hospital setting, clinical ethicists are learning as this pandemic progresses. What is certain is that processes for engaging in shared decision-making will look quite different post-pandemic than they did pre-pandemic. The pandemic will almost certainly change how ICU physicians communicate with patients and/or families at the end of life.

12.
Clin Infect Dis ; 71(16): 2211-2214, 2020 11 19.
Article in English | MEDLINE | ID: covidwho-1153136

ABSTRACT

Thousands of people in the United States have required testing for SARS-CoV-2. Evaluation for a special pathogen is resource intensive. We report an innovative approach to home assessment that, in collaboration with public health, enables safe evaluation and specimen collection outside the healthcare setting, avoiding unnecessary exposures and resource utilization.


Subject(s)
COVID-19/diagnosis , House Calls , Patient Care Team , Public Health/methods , Specimen Handling/methods , COVID-19/prevention & control , Clinical Laboratory Techniques , Humans , SARS-CoV-2 , Technology Assessment, Biomedical/methods , United States
14.
Clin Infect Dis ; 71(10): 2702-2707, 2020 12 17.
Article in English | MEDLINE | ID: covidwho-1059704

ABSTRACT

BACKGROUND: Healthcare workers (HCWs) who serve on the front lines of the coronavirus disease 2019 (COVID-19) pandemic have been at increased risk for infection due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in some settings. Healthcare-acquired infection has been reported in similar epidemics, but there are limited data on the prevalence of COVID-19 among HCWs and their associated clinical outcomes in the United States. METHODS: We established 2 high-throughput employee testing centers in Seattle, Washington, with drive-through and walk-through options for symptomatic employees in the University of Washington Medicine system and its affiliated organizations. Using data from these testing centers, we report the prevalence of SARS-CoV-2 infection among symptomatic employees and describe the clinical characteristics and outcomes among employees with COVID-19. RESULTS: Between 12 March 2020 and 23 April 2020, 3477 symptomatic employees were tested for COVID-19 at 2 employee testing centers; 185 (5.3%) employees tested positive for COVID-19. The prevalence of SARS-CoV-2 was similar when comparing frontline HCWs (5.2%) with nonfrontline staff (5.5%). Among 174 positive employees reached for follow-up at least 14 days after diagnosis, 6 reported COVID-related hospitalization; all recovered. CONCLUSIONS: During the study period, we observed that the prevalence of positive SARS-CoV-2 tests among symptomatic HCWs was comparable to that of symptomatic nonfrontline staff. Reliable and rapid access to testing for employees is essential to preserve the health, safety, and availability of the healthcare workforce during this pandemic and to facilitate the rapid return of SARS-CoV-2-negative employees to work.


Subject(s)
COVID-19 , COVID-19 Testing , Health Personnel , Humans , Prevalence , SARS-CoV-2 , Washington/epidemiology
15.
Radiology ; 296(2): E26-E31, 2020 08.
Article in English | MEDLINE | ID: covidwho-1043320

ABSTRACT

The coronavirus disease 2019 (COVID-19) pandemic initially manifested in the United States in the greater Seattle area and has rapidly progressed across the nation in the past 2 months, with the United States having the highest number of cases in the world. Radiology departments play a critical role in policy and guideline development both for the department and for the institutions, specifically in planning diagnostic screening, triage, and management of patients. In addition, radiology workflows, volumes, and access must be optimized in preparation for the expected surges in the number of patients with COVID-19. In this article, the authors discuss the processes that have been implemented at the University of Washington in managing the COVID-19 pandemic as well in preparing for patient surges, which may provide important guidance for other radiology departments who are in the early stages of preparation and management.


Subject(s)
COVID-19 , Health Policy , COVID-19/diagnosis , COVID-19/therapy , Disaster Planning , Hospitalization , Hospitals, University , Humans , Pandemics , Practice Guidelines as Topic , Radiology Department, Hospital/legislation & jurisprudence , Radiology Department, Hospital/organization & administration , Radiology Department, Hospital/statistics & numerical data , SARS-CoV-2 , Washington
17.
Ann Surg ; 273(6): 1051-1059, 2021 06 01.
Article in English | MEDLINE | ID: covidwho-998569

ABSTRACT

The emergence of coronavirus disease 2019 (COVID-19) that is caused by the SARS-CoV-2 virus has led to an overwhelming strain on healthcare delivery. This pandemic has created a sustained stress on the modern healthcare system, with unforeseen and potential drastic effects. Although the initial focus during this pandemic has been preparedness and response directed to the pandemic itself, traumatic injury has continued to remain a common problem that requires immediate evaluation and care to provide optimal outcomes. The State of Washington had the first reported case and death related to COVID-19 in the United States. Harborview Medical Center, which serves as the sole Level-1 adult and pediatric trauma center for the state, was rapidly affected by COVID-19, but still needed to maintain preparedness and responses to injured patients for the region. Although initially the focus was on the emerging pandemic on institutional factors, it became obvious that sustained efforts for regional trauma care required a more global focus. Because of these factors, Harborview Medical Center was quickly entrusted to serve as the coordinating center for the regions COVID-19 response, while also continuing to provide optimal care for injured patients during the pandemic. This response allowed the care of injured patients to be maintained within designated trauma centers during this pandemic. This present report summarizes the evolution of trauma care delivery during the first phase of this pandemic and provides informative recommendations for sustained responses to the care of injured patients during the pandemic based on lessons learned during the initial response.


Subject(s)
COVID-19/epidemiology , Delivery of Health Care/trends , Disaster Planning , Pneumonia, Viral/epidemiology , Trauma Centers/organization & administration , Humans , Pandemics , Pneumonia, Viral/virology , SARS-CoV-2 , United States/epidemiology , Washington/epidemiology
18.
Am J Infect Control ; 49(3): 293-298, 2021 03.
Article in English | MEDLINE | ID: covidwho-722286

ABSTRACT

BACKGROUND: We describe key characteristics, interventions, and outcomes of a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak within an inpatient geriatric psychiatry unit at the University of Washington Medical Center - Northwest. METHODS: After identifying 2 patients with SARS-CoV-2 infection on March 11, 2020, we conducted an outbreak investigation and employed targeted interventions including: screening of patients and staff; isolation and cohorting of confirmed cases; serial testing; and enhanced infection prevention measures. RESULTS: We identified 10 patients and 7 staff members with SARS-CoV-2 infection. Thirty percent of patients (n = 3) remained asymptomatic over the course of infection. Among SARS-CoV-2 positive patients, fever (n = 5, 50%) and cough (n = 4, 40%) were the most common symptoms. Median duration of reverse transcription polymerase chain reaction (RT-PCR) positivity was 25.5 days (interquartile range [IQR] 22.8-41.8) among symptomatic patients and 22.0 days (IQR 19.5-25.5) among asymptomatic patients. Median initial (19.0, IQR 18.7-25.7 vs 21.7, IQR 20.7-25.6) and nadir (18.9, IQR 18.2-20.3 vs 19.8, IQR 17.0-20.7) cycle threshold values were similar across symptomatic and asymptomatic patients, respectively. CONCLUSIONS: Asymptomatic infection was common in this cohort of hospitalized, elderly individuals despite similar duration of SARS-CoV-2 RT-PCR positivity and cycle threshold values among symptomatic and asymptomatic patients.


Subject(s)
COVID-19 Nucleic Acid Testing/statistics & numerical data , COVID-19/epidemiology , Geriatric Psychiatry/statistics & numerical data , Inpatients/statistics & numerical data , Psychiatric Department, Hospital/statistics & numerical data , SARS-CoV-2 , Aged , Aged, 80 and over , Asymptomatic Infections/epidemiology , COVID-19/blood , Disease Outbreaks , Female , Humans , Male , Middle Aged , Prospective Studies , Washington/epidemiology
19.
J Am Coll Surg ; 231(3): 316-324.e1, 2020 09.
Article in English | MEDLINE | ID: covidwho-599260

ABSTRACT

BACKGROUND: Washington State experienced the first major outbreak of COVID-19 in the US and despite a significant number of cases, has seen a relatively low death rate per million population compared with other states with major outbreaks, and has seen a substantial decrease in the projections for healthcare use, that is, "flattening the curve." This consensus report seeks to identify the key factors contributing to the effective health system disaster response in western WA. METHODS: A multidisciplinary, expert panel including individuals and organizations who were integral to managing the public health and emergency healthcare system response were engaged in a consensus process to identify the key themes and lessons learned and develop recommendations for ongoing management of the COVID-19 pandemic. RESULTS: Six key themes were identified, including early communication and coordination among stakeholders; regional coordination of the healthcare system response; rapid development and access to viral testing; proactive management of long-term care and skilled nursing facilities; proactive management of vulnerable populations; and effective physical distancing in the community. CONCLUSIONS: Based on the lessons learned in each of the areas identified by the panel, 11 recommendations are provided to support the healthcare system disaster response in managing future outbreaks.


Subject(s)
Betacoronavirus , Communicable Disease Control/organization & administration , Coronavirus Infections/epidemiology , Coronavirus Infections/prevention & control , Delivery of Health Care/organization & administration , Pandemics/prevention & control , Pneumonia, Viral/epidemiology , Pneumonia, Viral/prevention & control , COVID-19 , Communication , Coronavirus Infections/diagnosis , Emergency Medical Services/organization & administration , Humans , Long-Term Care/organization & administration , Pneumonia, Viral/diagnosis , SARS-CoV-2 , Stakeholder Participation , Washington/epidemiology
20.
J Oral Maxillofac Surg ; 78(7): 1136-1146, 2020 07.
Article in English | MEDLINE | ID: covidwho-133480

ABSTRACT

The emergence of coronavirus disease 2019 (COVID-19), caused by the SARS-CoV-2 (SC2) virus, in late December 2019 has placed an overwhelming strain on healthcare institutions nationwide. The modern healthcare system has never managed a pandemic of this magnitude, the ramifications of which will undoubtedly lead to lasting changes in policy and protocol development for viral testing guidelines, personal protective equipment (PPE), surgical scheduling, and residency education and training. The State of Washington had the first reported case and death related to COVID-19 in the United States. Oral and maxillofacial surgeons have a unique risk of exposure to SC2 and developing COVID-19 because of our proximity of working in and around the oropharynx and nasopharynx. The present report has summarized the evolution of COVID-19 guidelines in 4 key areas: 1) preoperative SC2 testing; 2) PPE stewardship; 3) surgical scheduling guidelines; and 4) resident education and training for oral and maxillofacial surgery at the University of Washington, Seattle, Washington.


Subject(s)
Coronavirus Infections , Pandemics , Patient Care/standards , Pneumonia, Viral , Practice Guidelines as Topic , Surgery, Oral/organization & administration , Appointments and Schedules , Betacoronavirus , COVID-19 , COVID-19 Testing , Clinical Laboratory Techniques , Coronavirus Infections/diagnosis , Humans , Internship and Residency , Personal Protective Equipment/standards , Pneumonia, Viral/diagnosis , SARS-CoV-2 , Washington
SELECTION OF CITATIONS
SEARCH DETAIL